These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 9162643)

  • 1. [Peroxide-induced damage to high-density lipoproteins and their cholesterol-acceptor function in patients with ischemic heart disease and in healthy people].
    Plavinskiĭ SL; Kuznetsov AS
    Fiziol Cheloveka; 1997; 23(1):103-7. PubMed ID: 9162643
    [No Abstract]   [Full Text] [Related]  

  • 2. [Content of lipid peroxidation products in the urine of patients with ischemic heart disease].
    Plavinskiĭ SL
    Fiziol Cheloveka; 1998; 24(3):121-5. PubMed ID: 9742749
    [No Abstract]   [Full Text] [Related]  

  • 3. Lipid peroxidative damage in the erythrocytes and elevation of serum LDL-cholesterol, apolipoprotein-B, ferritin and uric acid with age and in coronary heart disease patients.
    El-Gebali HH; Tahir SA; Haider SS; El-Fakhri MM
    Saudi Med J; 2000 Feb; 21(2):184-9. PubMed ID: 11533779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathogenetic significance of cholesterol-containing immune complexes and lipid peroxidation in ischemic heart disease].
    Urazgil'deeva SA; Shatalina LV; Gurevich VS
    Ter Arkh; 1999; 71(12):8-10. PubMed ID: 10647190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levels of non-high density lipoprotein cholesterol (non-HDL-C) in patients with ischaemic heart disease.
    Tauheed S; Shoaib S; ul Haque MN
    J Ayub Med Coll Abbottabad; 2003; 15(1):33-4. PubMed ID: 12870314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of serum levels of homocystein, lipids and their peroxidation products in patients with coronary heart disease].
    Belaia OL; Fedorova NV
    Klin Med (Mosk); 2005; 83(11):30-3. PubMed ID: 16404936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of hyperlipidemia on QT dispersion in patients without ischemic heart disease.
    Szabó Z; Harangi M; Lörincz I; Seres I; Katona E; Karányi Z; Paragh G
    Can J Cardiol; 2005 Aug; 21(10):847-50. PubMed ID: 16107907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular diseases in patients with high levels of plasma high density lipoprotein: association with increased plasma oxidative state.
    Shimoni N; Kaplan M; Keidar S
    Isr Med Assoc J; 2003 Oct; 5(10):702-5. PubMed ID: 14719463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lipid peroxidation in ischemic heart disease].
    Golikov AP; Golikov PP; Davydov BV; Polumiskov VIu; Riabinin VA; Marchenko VV
    Fiziol Cheloveka; 1997; 23(6):49-57. PubMed ID: 9494268
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of antioxidant serum levels of myocardial ischemia markers in patients with ischemic heart disease after treadmill exercise testing.
    Hasso NM; Al-Rubayi HA; El-Yassin HD
    Saudi Med J; 2005 Sep; 26(9):1473-5. PubMed ID: 16155676
    [No Abstract]   [Full Text] [Related]  

  • 11. The function, composition, and particle size of high-density lipoprotein were severely impaired in an oliguric phase of hemorrhagic fever with renal syndrome patients.
    Cho KH; Park SH; Park JE; Kim YO; Choi I; Kim JJ; Kim JR
    Clin Biochem; 2008 Jan; 41(1-2):56-64. PubMed ID: 17996200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment.
    Ansell BJ; Navab M; Hama S; Kamranpour N; Fonarow G; Hough G; Rahmani S; Mottahedeh R; Dave R; Reddy ST; Fogelman AM
    Circulation; 2003 Dec; 108(22):2751-6. PubMed ID: 14638544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of lipids and lipoproteins in Syrian patients with beta-thalassemia major.
    Al-Quobaili FA; Abou Asali IE
    Saudi Med J; 2004 Jul; 25(7):871-5. PubMed ID: 15235691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-density lipoprotein function recent advances.
    Ansell BJ; Watson KE; Fogelman AM; Navab M; Fonarow GC
    J Am Coll Cardiol; 2005 Nov; 46(10):1792-8. PubMed ID: 16286161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of triglycerides-to-high-density lipoprotein cholesterol ratio for predicting the first coronary event in men.
    Cordero A; Andrés E; Ordoñez B; León M; Laclaustra M; Grima A; Luengo E; Moreno J; Bes M; Pascual I; Civeira F; Pocoví M; Alegría E; Casasnovas JA;
    Am J Cardiol; 2009 Nov; 104(10):1393-7. PubMed ID: 19892056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of high-density lipoprotein cholesterol in patients with low low-density lipoprotein cholesterol.
    deGoma EM; Leeper NJ; Heidenreich PA
    J Am Coll Cardiol; 2008 Jan; 51(1):49-55. PubMed ID: 18174036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Aerobic-hemodynamic support of physical exertion in virtually healthy persons with different levels of cholesterol in the blood and in patients with stenocardia of effort].
    Vasil'ev AP; Strel'tsova NN; Senatorov IuN; Zimina TP
    Patol Fiziol Eksp Ter; 1999; (4):27-9. PubMed ID: 10598461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerivastatin modulates antiatherogenic properties of high-density lipoproteins in patients with coronary heart disease and hyperlipidemia.
    Ozerova IN; Jeevan DM; Serdyuk AP; Paramonova IV; Akhmedzhanov NM; Metel'skaya VA; Perova NV
    Bull Exp Biol Med; 2000 Oct; 130(10):983-5. PubMed ID: 11177300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-density lipoproteins from human alcoholics exhibit impaired reverse cholesterol transport function.
    Rao MN; Liu QH; Marmillot P; Seeff LB; Strader DB; Lakshman MR
    Metabolism; 2000 Nov; 49(11):1406-10. PubMed ID: 11092502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor.
    Theilmeier G; Schmidt C; Herrmann J; Keul P; Schäfers M; Herrgott I; Mersmann J; Larmann J; Hermann S; Stypmann J; Schober O; Hildebrand R; Schulz R; Heusch G; Haude M; von Wnuck Lipinski K; Herzog C; Schmitz M; Erbel R; Chun J; Levkau B
    Circulation; 2006 Sep; 114(13):1403-9. PubMed ID: 16982942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.